Orsolya Rusz

548 total citations
19 papers, 317 citations indexed

About

Orsolya Rusz is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Orsolya Rusz has authored 19 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Orsolya Rusz's work include DNA Repair Mechanisms (7 papers), PARP inhibition in cancer therapy (7 papers) and HER2/EGFR in Cancer Research (5 papers). Orsolya Rusz is often cited by papers focused on DNA Repair Mechanisms (7 papers), PARP inhibition in cancer therapy (7 papers) and HER2/EGFR in Cancer Research (5 papers). Orsolya Rusz collaborates with scholars based in Hungary, Denmark and United States. Orsolya Rusz's co-authors include Zoltán Szállási, Sándor Spisák, Zsófia Sztupinszki, Miklós Dióssy, István Csabai, Zsuzsanna Kahán, Viktória Tisza, Gábor Cserni, Marek Krzystanek and Dávid Szüts and has published in prestigious journals such as Clinical Cancer Research, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Orsolya Rusz

19 papers receiving 317 citations

Peers

Orsolya Rusz

ONCOL

PRM

GENET

Emma Killick United Kingdom

R. Dent Spain

Mitsugu Yamamoto Japan

Marcos Díaz‐Gay United States

Jaime Miguel Gomes Pita Belgium

Tabari M. Baker United States

Lingzhu Wen China

Daniela Boggiani Italy

S. Kappel Austria

Yvonne H. C. M. Smolders Netherlands

Emma Killick United Kingdom

Orsolya Rusz

135 ×0.7

ONCOL

116 ×0.8

42 ×0.4

PRM

69 ×0.7

64 ×1.2

GENET

Citations per year, relative to Orsolya Rusz Orsolya Rusz (= 1×) peers Emma Killick

Countries citing papers authored by Orsolya Rusz

Since Specialization

Citations

This map shows the geographic impact of Orsolya Rusz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orsolya Rusz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orsolya Rusz more than expected).

Fields of papers citing papers by Orsolya Rusz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orsolya Rusz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orsolya Rusz. The network helps show where Orsolya Rusz may publish in the future.

Co-authorship network of co-authors of Orsolya Rusz

This figure shows the co-authorship network connecting the top 25 collaborators of Orsolya Rusz. A scholar is included among the top collaborators of Orsolya Rusz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orsolya Rusz. Orsolya Rusz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Pipek, Orsolya, Donát Alpár, Orsolya Rusz, et al.. (2023). Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort. International Journal of Molecular Sciences. 24(10). 8553–8553. 2 indexed citations

Pipek, Orsolya, Janina Kulka, Orsolya Rusz, et al.. (2022). Investigating the Prognostic Relevance of Tumor Immune Microenvironment and Immune Gene Assembly in Breast Carcinoma Subtypes. Cancers. 14(8). 1942–1942. 1 indexed citations

Dióssy, Miklós, Zsófia Sztupinszki, Viktória Tisza, et al.. (2021). Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer. Clinical Cancer Research. 27(13). 3734–3743. 18 indexed citations

Buzás, György Miklós, Orsolya Rusz, Attila Szíjártó, et al.. (2021). Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study. Pathology & Oncology Research. 27. 1609863–1609863. 7 indexed citations

Dióssy, Miklós, Zsófia Sztupinszki, Marek Krzystanek, et al.. (2021). A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures. npj Precision Oncology. 5(1). 55–55. 19 indexed citations

Sztupinszki, Zsófia, Miklós Dióssy, Marek Krzystanek, et al.. (2020). Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations. Clinical Cancer Research. 26(11). 2673–2680. 56 indexed citations

Kahán, Zsuzsanna, et al.. (2019). Cognitive Functioning and Psychological Well-being in Breast Cancer Patients on Endocrine Therapy. In Vivo. 33(4). 1381–1392. 14 indexed citations

Póti, Ádám, Eszter Németh, Orsolya Rusz, et al.. (2019). Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents. Genome biology. 20(1). 240–240. 72 indexed citations

Tõkés, Anna‐Mária, Orsolya Rusz, Gábor Cserni, et al.. (2019). Influence of mutagenic versus non-mutagenic pre-operative chemotherapy on the immune infiltration of residual breast cancer. Acta Oncologica. 58(11). 1603–1611. 3 indexed citations

10.

Sztupinszki, Zsófia, Miklós Dióssy, Marek Krzystanek, et al.. (2019). Prevalence of homologous recombination deficiency (HRD)-related signatures indicates that a wider range of prostate cancer patients may benefit from PARP-inhibitor therapy. Annals of Oncology. 30. vii14–vii14. 1 indexed citations

11.

Dióssy, Miklós, Lilla Reiniger, Zsófia Sztupinszki, et al.. (2018). Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors. Annals of Oncology. 29(9). 1948–1954. 53 indexed citations

12.

Rusz, Orsolya, et al.. (2018). Clinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case series. OncoTargets and Therapy. Volume 11. 5459–5463. 17 indexed citations

13.

Rusz, Orsolya, Laura Vízkeleti, Béla Molnár, et al.. (2018). LAPTM4B gene copy number gain is associated with inferior response to anthracycline-based chemotherapy in hormone receptor negative breast carcinomas. Cancer Chemotherapy and Pharmacology. 82(1). 139–147. 1 indexed citations

14.

Rusz, Orsolya, Margit Pál, László Rovó, et al.. (2016). The Expression of Checkpoint and DNA Repair Genes in Head and Neck Cancer as Possible Predictive Factors. Pathology & Oncology Research. 23(2). 253–264. 6 indexed citations

15.

Rusz, Orsolya, András Vörös, Zoltán Varga, et al.. (2015). One-Year Neoadjuvant Endocrine Therapy in Breast Cancer. Pathology & Oncology Research. 21(4). 977–984. 13 indexed citations

16.

Hidéghety, Katalin, et al.. (2015). [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].. PubMed. 59(2). 103–10. 2 indexed citations

17.

Kővári, Bence, Orsolya Rusz, Andrew V. Schally, Zsuzsanna Kahán, & Gábor Cserni. (2014). Differential immunostaining of various types of breast carcinomas for growth hormone‐releasing hormone receptor – Apocrine epithelium and carcinomas emerging as uniformly positive. Apmis. 122(9). 824–831. 11 indexed citations

18.

Vörös, András, Bence Kővári, Péter Lázár, et al.. (2014). Different Methods of Pretreatment Ki-67 Labeling Index Evaluation in Core Biopsies of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Their Relation to Response to Therapy. Pathology & Oncology Research. 21(1). 147–155. 18 indexed citations

19.

Rusz, Orsolya & Zsuzsanna Kahán. (2012). Bone Homeostasis and Breast Cancer: Implications for Complex Therapy and the Maintenance of Bone Integrity. Pathology & Oncology Research. 19(1). 1–10. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact